Radioactive iodine therapy in graves' hyperthyroidism: A prospective study from a tertiary referral centre in North India

Journal of Association of Physicians of India

Volumn 53, Issue JUL, 2005, Pages 603-606

  Sankar, R ^a   Sekhri, T ^a   Sripathy, G ^a   Walia, R P ^a   Jain, S K ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; BLOOD; DRUG EFFECT; FEMALE; GRAVES DISEASE; HOSPITAL; HUMAN; HYPERTHYROIDISM; INDIA; MALE; MIDDLE AGED; NODULAR GOITER; PATHOLOGY; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOIMMUNOASSAY; THYROID GLAND; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GOITER, NODULAR; GRAVES DISEASE; HOSPITALS; HUMANS; HYPERTHYROIDISM; INDIA; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RADIOTHERAPY DOSAGE; THYROID GLAND; THYROID HORMONES; THYROTROPIN; TREATMENT OUTCOME;

EID: 24644504083     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. st ed. Philadelphia: Lippincott; 1990;331-347.
2. Beierwaltes WH. Treatment of hyperthyroidism with iodine 131. Semin Nucl Med 1978;8:95-103.
3. Sawin CT, Becker DV. Radioiodine and treatment of hyperthyroidism: The early history. Thyroid 1997;7:163-176.
4. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990;70:1518-24.
5. 131I therapy. Lancet 1976;2:73.
6. 131I therapy for Graves' disease. N Engl J Med 1984;311:426-31.
7. Wise PH, Burnet RB, Ahmad A, Harding PE. Intentional radioiodine ablation in Graves' disease. Lancet 1975;1:1231-32.
8. 131I. Arch Intern Med 1975;135:673-75.
9. 131dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991;32:411-16.
10. Guidelines for the use of radioiodine in the management of hyperthyroidism : A summary. Prepared by the radioiodine audit subcommittee of the Royal College of Physicians Committee on diabetes and endocrinology and the research unit of the Royal College of Physicians. J R Coll Physicians London 1995;29:464-69.
11. Alevizaki CC, Alevizaki-Harhalaki, Ikkos DG. Radioiodine -131 treatment of thyrotoxicosis :dose required for and some factors affecting the early induction of hypothyroidism. Eur J Nucl Med 1985;10:450-54.
12. 131I therapy of thyrotoxicosis(diffuse goiters). A five-year follow-up study. N Eng J Med 1974;290:141-44.
13. Becker DV, McConahey WM, Dobins BM , et al. The results of thyrotoxicosis therapy follow up study.In:Fellinger K,Hofer R (eds).Further advances in thyroid research. Vienna:G Gitsel und Cie 1971;1:603-609.
14. Gopinath PG, Prasanna Kumari KM, Padhy AK, Aggarwal SL. Thyroid status 10 years after I-131 therapy for toxic diffuse goiter. Indian J Nucl Med 1989;4:8-10.
15. Nair N. Results of a single 5 mCi dose of radioactive iodine in thyrotoxicosis. Indian J Nucl Med 1991;6:6-11.
16. DunnJT. Choice of therapy in young adults with hyperthyroidism of Graves'disease : a brief case -directed poll of fifty-four thyroidologists. Ann Intern Med 1984;100;891-93.
17. 131I therapy for hyperthyroidism. Acta Radiol 1981;20:225-30.
18. 131I therapy for hyperthyroidism in relation to immunologic parameters. Acta Radiol Oncol 1980;19:449-54.